Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to Treatment

Eleni Maniati1, Chiara Berlato1, Ganga Gopinathan1

  • 1Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK.

Cell Reports
|January 16, 2020
PubMed

Insights

New murine models of high-grade serous ovarian cancer (HGSOC) mimic the human tumor microenvironment (TME). These models predict patient response to chemotherapy and targeted therapies, aiding drug development.

Area of Science:

  • Oncology
  • Cancer Biology
  • Translational Research

Background:

  • The tumor microenvironment (TME) is a complex system crucial for high-grade serous ovarian cancer (HGSOC) progression.
  • Pre-clinical testing of potential therapies for HGSOC is hindered by limited understanding of the murine TME.
  • Developing accurate pre-clinical models is essential for advancing HGSOC treatment strategies.

Observation:

  • Six orthotopic, transplantable syngeneic murine HGSOC lines were established and characterized.
  • The murine TME was compared to human HGSOC patient biopsies.
  • Correlations were identified between the transcriptome, host cell infiltrates, matrisome, vasculature, and tissue modulus in both mouse and human TMEs.

Findings:

  • Significant correlations were observed between murine and human TMEs, revealing common stromal and malignant targets.
  • Distinct differences and potential vulnerabilities were identified in each murine model.
  • Machine learning analysis of transcriptional profiles from mouse models successfully classified chemotherapy-sensitive and -refractory patient tumors.

Implications:

  • These characterized murine HGSOC models serve as valuable pre-clinical tools for therapeutic testing.
  • The models can help predict patient responses to chemotherapy and targeted agents like anti-IL-6 antibodies.
  • This research may facilitate the identification of HGSOC patient subgroups likely to benefit from specific therapies.